Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
5 January 2017
Header
Header image
Highlight of the week

Highlight of the week

IMI 2 - Call 10
05 January 2017

Submission is now OPEN for IMI2 - Call 10. Stage 1 submission deadline is 28 March 2017.

For more information, click here.

Read more

From our blog

From our blog

The Value Pharma Places on Circular Economy
05 January 2017 by John Atkinson and Wesley White

So why is a circular economy important to EFPIA? The driving motivation of the pharmaceutical industry is to improve human health and well-being. With nearly a quarter of global deaths attributable to the environment (UNEP, 2016. Healthy Environment, Healthy People), we recognise that reducing our environmental footprint is an important step we can take to positively impact human health. A shift to a circular economy could bring many health benefits. For example, optimising materials and processes to reduce our carbon footprint will help to combat climate change – described as the greatest opportunity to advance human health in the 21st Century.

Read more

From our blog

Clinical trials are only as credible as their outcomes (Guest blog)
05 January 2017 by Paula Williamson

Every year, hundreds of thousands of members of the public are recruited into tens of thousands of clinical trials in health and social care, and thousands of researchers prepare systematic reviews to bring together the findings of existing trials. Much of this effort is wasted if the outcomes measured and reported are not those needed by health service users, practitioners, health technology assessment (HTA) agencies, policy makers and others, making choices between or reimbursement decisions about different interventions, actions and strategies. Considering Peter Tugwell’s view that “Clinical trials are only as credible as their outcomes”, one can see this is equally true for systematic reviews, clinical guidelines, health technology assessments, and healthcare organisations.

Read more

Events calendar

Events Calendar

The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment - European Meeting of the International Society for Medical Publication Professionals (ISMPP)
From 17/01/2017 to 18/01/2017 (London, UK)

The 2017 European Meeting of the International Society for Medical Publication Professionals (ISMPP) will be held 17-18 January, in London, UK, and it will focus on “The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment”. Two full days of educational programming will provide networking opportunities, interactive roundtables, plenary sessions, member research, and exhibitors displaying cutting edge products and services.

Read more

Events Calendar

Patients as Partners Europe
From 06/02/2017 to 07/02/2017 (London, UK)

Patients as Partners Europe is the only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical development and trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Goverment. The programme is co-located with DPharm Europe. 

Read more

Documents

From our blog

EFPIA White Paper on Circular Economy
05 January 2017 (Publications)

Executive Summary -  The European Commission’s Circular Economy Action Plan has established targets for the reduction of waste, waste management and recycling, but clear details of [...] Read more

What we are reading

What we are reading

Report by Charles River Associates: use of managed entry agreements for products with conditional or exceptional authorisations
05 January 2017 (IMI ADAPT SMART)

The European Federation of Pharmaceutical Industries and Associations (EFPIA) asked Charles River Associates (CRA) to undertake an interview programme to understand how managed entry agreements (MEA) have been used for products with Conditional Marketing Authorisations or Marketing Authorisations under exceptional circumstances as a proxy for Medicines Adaptive Pathways to Patients (MAPPs).

Read more

What we are reading

Only Just Begun
05 January 2017 (ABPI)

‘Only Just Begun’ celebrates the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail